Spruce Point Capital – Caesarstone Ltd (CSTE) – Nothing On The Counter

Spruce Point Capital Management wants to alert our readers to a new research report on Caesarstone (Nasdaq: CSTE) by an independent firm called Viceroy Research, which was released earlier today. We believe this report strengthens our views that CSTE is at best a $15 stock. [timeless variation=”investment”]  CSTE’s major revenue growth product, marketed as a collaboration with Lowe’s, is not for sale according to Lowe’s Customer Services and store checks. This is contrary sell-side forecasts highlighting this as a growth driver. Of CSTE’s listed sales agents, there is a growing percentage no longer sell (or have never sold) CSTE products,…